Building on previous success, SMi proudly announces the return of 3rd Annual Biosimilars USA  conference to New Jersey in November 2016!

It's without doubts that the biosimilars market present lucrative opportunities for pharmaceuticals and biotech companies. Over the last 12 months, market participants have witnessed revolutionary steps in the US to facilitate commercialization.

It's now time for industry colleagues to act, and to act fast to seize such opportunities. The 3rd A nnual Biosimilars USA meeting will update you with the latest market developments and regulatory updates to ensure you stay at the forefront of this evolving market! 

Join us today  to:

  • Hear latest regulatory updates for smooth and speedy  approval
  • Learn successful biosimilar case studies to reshape your business model
  • Dissect regional market growth opportunities - where should you go next ?
  • Network with like-minded senior experts and engage in interactive debates


CEOs, Chiefs, VPs, Directors, Principals, Heads, Managers of:

  • Biosimilars/ Biobetters
  • Portfolio Management & Strategy
  • CSO
  • Alliance Management
  • Business Development
  • Regulatory Affairs
  • Commercial
  • Planning

or anyone working with Biosimilars and Biobetters from pharmaceutical, biotechs and solution providers.

Abzena, Alston & Bird LLP, Apobiologix, Austrian Agency for Health & Food Safety, Bespak, Bio Outsource, Boehringer Ingelheim Pharmaceuticals, Inc., Bristows, Dr. Reddy's Laboratories, Formycon AG, Genentech, Harvest Moon Pharmaceuticals, Hospira,  IMS Health Inc., Johnson & Johnson, Janssen, Medimmune, Merck, EMD Serono, Norwegian Medicines Agency, Oncobiologics, PAREXEL, Samsung Bioepis, Sandoz AG, Sandoz Inc., Schwegman Lundberg Woessner, Selecta Biosciences, STC Biologics Inc., Teva Pharmaceuticals, Wyatt Health Management and many more! 

Conference programme

8:00 Registration & Coffee

8:30 Chairman's Opening Remarks

Rodeina Challand

Rodeina Challand, Director, Challand Biosimilar Consulting

8:40 What to Expect? Regulatory Agency's Update on Biosimilars Application

Cindy Cao

Cindy Cao, Executive Director & Head of US Regulatory Affairs for Biopharmaceuticals, Sandoz Inc

  • Health authority perspectives on regulation of biosimilars (US, EU and other regions)
    > Totality of evidence
    > Data expectations
    > Naming
    > Labeling
    > Substitution and interchangeability
  • Extrapolation is a reality
  • Are immunogenicity concerns about biosimilars scientifically valid?
  • Can a company develop a single global biosimilar application?
  • 9:20 Regulatory Concerns for Interchangeability - Time to Define and Clarify

    Brad Jordan

    Brad Jordan, Director, Regulatory Affairs and R&D Policy, Amgen Inc.

  • What's in a name? Differentiating European and US terms and policies
  • What are the concerns? Medically-guided switching vs. pharmacy substitution
  • What's the standard? Survey of perspectives from policy makers and industry
  • What's next? Labelling, naming and pharmacy practice
  • 10:00 Put Aside Your Status as a Generic, Biosimilar, Innovator or Sponsor? How Can You Beat the Big Guys? (Part 1)

  • Barriers to market
    > Difficulties and dead-ends of R&D to make a biological
    > Obtaining FDA/State/EP and/or Asian Governments' regulatory approval
    > Cost and patent considerations
  • How to overcome?
    > Search and identify patents early - prepare in advance of BPCIA
    > Thorough evaluation of cost of bioequivalent work vs new biological with full clinical data
    > Do not be a Lemming: Avoid running as a 'herd' off the edge of a cliff
  • Robin Chadwick

    Robin Chadwick, Principal, Schwegman Lundberg Woessner

    Albin James Nelson

    Albin James Nelson, Senior Shareholder, Schwegman Lundberg Woessner

    10:50 Morning Coffee & Networking Break

    11:20 Biosimilars – Lessons Learned in Europe

    Steinar Madsen

    Steinar Madsen, Medical Director, Norwegian Medicines Agency

  • What decides uptake in clinical practice?
  • From biosimilar to biogeneric?
  • The future of biosimilars?
  • 12:00 The emergency scenario of biosimilars in Brazil

    Andrew Simpson

    Andrew Simpson, Scientific Director, Orygen Biotechnologia S/A

  • Public sector vs. private sector
  • Local manufacturing
  • 12:40 Networking Lunch

    13:50 Succeeding with Biosimilars in Canada

    George Wyatt

    George Wyatt, Managing Director, Wyatt Health Management

  • Regulatory path at Health Canada - different from FDA and EMA
  • Common drug review tailored review process
  • Negotiations at the pan-Canadian Pharmaceutical Alliance
  • Public and private drug plan coverage: New patients vs switching; preferential listings, anyone?
  • 14:30 Overview of Biosimilars Industry in China

    15:10 Afternoon Tea & Networking Break

    15:40 Leveraging Successful Patient Recruitment & Retention Strategies in Biosimilars Research

    Shazia Ahmad

    Shazia Ahmad, Director, Patient & Physician Services, UBC - An Express Scripts Company

  • How to plan a successful clinical trial for biosimilars?        
  • Talk to your stakeholders
  • Executing key strategies for a successful biosimilars clinical trials
  • 16:20 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Rodeina Challand

    Rodeina Challand, Director, Challand Biosimilar Consulting

    9:10 Characterization of Innovator and Biosimilar Antibody Molecules

    T. Shantha Raju

    T. Shantha Raju, Senior Director of Analytical Sciences, MedImmune Inc.

  • Analytical characterization
  • Novel methods to distinguish
  • Clinical relevance of differences
  • 9:50 The Importance of Early Immunogenicity and Product Quality Assessment (PQA) in Biosimilar Development

    Gary  Bembridge

    Gary Bembridge, Director Scientific Affairs, Abzena

  • Understanding the causes and variations of immunogenicity between biosimilars and originators
  • Case study: EPO vs infliximab switching experiences
  • Methods for preclinical immunogenicity and PQA for early comparative analysis
  • De-risking approaches for biosimilars and biobetters
  • 10:30 Morning Coffee & Networking Break

    11:00 Why Successful Commercialization of Biosimilars is Important to Vizient

    L. Ross Day, R.Ph. D.P.

    L. Ross Day, R.Ph. D.P., Director of Pharmacy, Sourcing Operations, Vizient Inc.

  • What is Vizient and who do we represent (50% of the US Acute Care Hospitals and 25% of Non-Acute Providers)
  • The size of biological spend in Vizient hospitals and the potential impact for biosimilar price reductions
  • Vizient's efforts to educate providers (hospitals and physicians) regarding myths that must be overcome to ensure successful commercialization of biosimilars
  • 11:40 Development of Biosimilars in South Korea

    Kevin Kyumin Lee

    Kevin Kyumin Lee, Partner, Kim & Chang

  • Overview and current trend of the biosimilars industry in Korea
  • Regulatory approval of biosimilars in Korea
  • Patent disputes related to biosimilars in Korea
  • 12:20 Networking Lunch

    13:30 Biosimilars: Key factors for successful uptake in the market

    Rodeina Challand

    Rodeina Challand, Director, Challand Biosimilar Consulting

    Short Abstract
    The regulatory pathways for the approval of biosimilars are well developed and tested globally.  Many countries throughout the world have established legal and regulatory pathways which allow development of biosimilar products. The EU is the first region in the world to have set a legal framework and a regulatory pathway for biosimilars. To date, EMA has approved 22 biosimilars within the product classes of human growth hormone, granulocyte colony-stimulating factor, erythropoiesis stimulating agent, follicular hormones, insulins and monoclonal antibodies for use in the EU. The legislative route creating biosimilars for the US market was created by the enacted healthcare reform law, the Patient Protection and Affordable Care Act (PPAC Act), signed into law in March 2010. The new law also included a pathway for an interchangeable biosimilar, which is a biological drug that can be automatically dispensed without specific prescriber authorization. To date FDA has approved two biosimilars, Zarxio (filgrastim-sndz), 6th March 2015 and Celltrion Inflectra (infliximab-dyyb), 6th April 2016.  The challenge is successful uptake in the market.
    This presentation will address:

  • Payer Policies
  • Regional variation- lack of optimization
  • Education
  • Clinical package
  • Interchangeability/ naming
  • The price
  • The patent dance
  • 14:10 Biosimilars – From Aspiration to Operations

    Edric Engert

    Edric Engert, SVP Biosimilars, Teva Pharmaceuticals

  • Corporate strategy
  • Portfolio strategy
  • Organizational implications
  • 14:50 Afternoon Tea

    15:20 Considerations for Commercial Success

    Molly Burich

    Molly Burich, Associate Director, Public Policy of Biosimilars, Pipeline, Reimbursement , Boehringer Ingelheim Pharmaceuticals, Inc

  • Engaging key stakeholders to drive biosimilar adoption
  • The big question of reimbursement of biosimilars in the US - what is the future and challenges?
  • 16:00 Panel Discussion: Marketing and Distribution – Keys to Success

  • How to market your biosimilars?
  • National and international distribution channels – working with hospitals and pharmacies
  • Competing with originators – challenges and solutions
  • Rodeina Challand

    Rodeina Challand, Director, Challand Biosimilar Consulting

    T. Shantha Raju

    T. Shantha Raju, Senior Director of Analytical Sciences, MedImmune Inc.

    Molly Burich

    Molly Burich, Associate Director, Public Policy of Biosimilars, Pipeline, Reimbursement , Boehringer Ingelheim Pharmaceuticals, Inc

    16:40 Chairman’s Closing Remarks and Close of Day Two



    Molly Burich

    Molly Burich

    Associate Director, Public Policy of Biosimilars, Pipeline, Reimbursement , Boehringer Ingelheim Pharmaceuticals, Inc
    Rodeina Challand

    Rodeina Challand

    Director, Challand Biosimilar Consulting

    Albin James Nelson

    Senior Shareholder, Schwegman Lundberg Woessner
    Albin James Nelson

    Andrew Simpson

    Scientific Director, Orygen Biotechnologia S/A
    Andrew Simpson

    Brad Jordan

    Director, Regulatory Affairs and R&D Policy, Amgen Inc.
    Brad Jordan

    Cindy Cao

    Executive Director & Head of US Regulatory Affairs for Biopharmaceuticals, Sandoz Inc
    Cindy Cao

    Edric Engert

    SVP Biosimilars, Teva Pharmaceuticals
    Edric Engert

    Gary Bembridge

    Director Scientific Affairs, Abzena
    Gary  Bembridge

    George Wyatt

    Managing Director, Wyatt Health Management
    George Wyatt

    George Wyatt

    Managing Director, Wyatt Health Management
    George Wyatt

    Kevin Kyumin Lee

    Partner, Kim & Chang
    Kevin Kyumin Lee

    L. Ross Day, R.Ph. D.P.

    Director of Pharmacy, Sourcing Operations, Vizient Inc.
    L. Ross Day, R.Ph. D.P.

    Molly Burich

    Associate Director, Public Policy of Biosimilars, Pipeline, Reimbursement , Boehringer Ingelheim Pharmaceuticals, Inc
    Molly Burich

    Robin Chadwick

    Principal, Schwegman Lundberg Woessner
    Robin Chadwick

    Rodeina Challand

    Director, Challand Biosimilar Consulting
    Rodeina Challand

    Shazia Ahmad

    Director, Patient & Physician Services, UBC - An Express Scripts Company
    Shazia Ahmad

    Steinar Madsen

    Medical Director, Norwegian Medicines Agency
    Steinar Madsen

    T. Shantha Raju

    Senior Director of Analytical Sciences, MedImmune Inc.
    T. Shantha Raju

    Sponsors and Exhibitors

    Official Media Partner



    Biosimilars : Considerations for Optimizing Access and Price

    Biosimilars : Considerations for Optimizing Access and Price

    Renaissance Woodbridge Hotel
    15th November 2016
    Iselin, USA

    A snapshot of confirmed attendees 2016


    Interview with Ross Day, Director of Pharmacy & Sourcing Ops, Vizient


    Interview with Harvest Moon Pharmaceuticals USA


    Interview with UBC - An Express Scripts Company


    List of 2015 Attendees


    Sponsors and Exhibitors


    Sponsors and Exhibitors

    Abzena offers a suite of complementary services and technologies. Its range of technologies include immunogenicity assessment, antibody drug conjugation, protein engineering, PEGylation, cell line development , GMP manufacturing and a range of bespoke assays to enables the development of better biopharmaceuticals which will have a greater chance of reaching the market.

    Schwegman, Lundberg & Woessner

    Sponsors and Exhibitors

    Schwegman Lundberg & Woessner is a nationally recognized boutique IP firm focused on strategic patent procurement with over 140 patent practitioners that have robust backgrounds across a wide spectrum of technology areas. Schwegman's clients include multinational corporations, middle-market businesses, universities, as well as start-ups and individual inventors.

    Wyatt Health Management

    Sponsors and Exhibitors

    Wyatt Health Management is Canada's leader in Biosimilars. We provide database offerings, payer market research and reimbursement consulting services in the Canadian market for pharmaceutical and non-drug technology firms. Established in 2002, we have developed a strong reputation for providing clients with customized, creative and practical solutions that address their public and private market access and reimbursement objectives, whether related to products or policy. Contact us. We would be pleased to help you succeed.

    Media Partners

    Colorado Bioscience

    Official Media Partner

    As champions for life science in our state, Colorado BioScience Association leads expansion policies to advance the industry and accelerate growth. We support a thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. CBSA fosters bioscience workforce and leadership development through opportunities for networking and professional education.


    Official Media Partner

    Established since 1998, Bio-Equip is a leading website for lab equipments, reagents, consumables and bio services. Our users come from different fields like life science, medical research, pharmaceutical, biotechnology, modern agriculture, food safety and environment monitoring. Bio-Equip offer users a complete product directory which involves 158 product ranges among lab equipments, reagents, consumables, lab animals, bio services, cell lines, bio software and books.Serving users through two websites, www.bio-equip.com (Chinese) and www.bio-equip.cn (English), we own over 20,000 registered suppliers and more than 500,000 pieces of product and technical service information with details of product description, price, sample downloading, technical articles and videos.

    BioChem Adda

    Official Media Partner

    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!

    Biosimilar News

    Official Media Partner

    BiosimilarNews.com is a leading international knowledge and information source about biosimilars. The site helps the industry professionals, clinicians and also the public to find timely and appropriate information about this specific area. Biosimilar News - We keep you up to date.

    American Pharmaceutical Review

    Official Media Partner

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy

    American Laboratory

    Official Media Partner

    For laboratory managers and researchers utilizing analytical chemistry and its applications, seeking knowledge on new technologies, methods, applications, and products, the American Laboratory® publication platform provides comprehensive technology coverage for laboratory professionals at all stages of their careers. Unlike single-channel publications, American Laboratory® is a multidisciplinary resource that engages scientists through print, digital, mobile, multimedia, and social channels to provide practical information and solutions for cutting-edge results. American Laboratory® serves the need of global community of laboratory professionals for communicating relevant technical advances and insights. Globally, American Laboratory® reaches out to subscribers by offering digital distribution plus premium print in North America. Digital communications utilize internet, mobile and social channels.

    Biosimilar Development

    Official Media Partner

    Biosimilar Development is dedicated to presenting technical information, thought leadership, and commentary for the biosimilar development and manufacturing community. On this site, users will find exclusive and actionable content on the industry trends and challenges affecting the emerging biosimilars market. Browse our articles, case studies, and white papers on topics related to biosimilar development, manufacturing, quality, distribution, FDA guidance, BPCIA, global markets, government regulations, and intellectual property. Biosimilar Development is part of the Life Science Connect media group, which strives to facilitate connections and foster collaborations in pharmaceutical development to find ways to get more life-saving and life-improving therapies to market. Connect, Collaborate, Contribute.

    Pharmaceutical Outsourcing

    Official Media Partner

    Welcome to Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry.

    Media Partners



    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.

    EIN News


    EIN News is the world leader in industry focused online news monitoring. Thousands of leading companies, institutions and global professionals from business, industry, and government rely on EIN News as an indispensable resource. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The news you need is then organized by advanced software systems managed by a team of professional news editors. Everything we do is focused on streamlining your news searches and research in order to save you time and money.

    Copybook - Pharmaceutical


    Copybook is a global business network with many pharmaceutical events, exhibitions and seminars. We encourage business-to-business transactions and work tirelessly to gain our customers new business contracts worldwide. You can add events, companies and associations for free. When you are a member, you can add your company to the events listed in order to encourage other visitors to arrange meetings and appointments at those events to facilitate new business contracts. Want to see how we can increase your business network and transactions? SIGN UP FOR FREE today! Copybook – Your Global Business Network





    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.



    FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!



    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.

    Inderscience Publishers


    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.



    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.



    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.

    Select Science


    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.

    Int. J. of Biotechnology


    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.



    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….



    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/

    BioPharm Insight


    BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive online interface and exclusive Active IntelT relational content technology, BioPharm Insight provides an unrivaled capability to segment and analyze the industry with detailed and searchable profiles.

    International Journal of Biomedical Engineering and Technology


    IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).

    International Journal of Bioinformatics Research and Applications


    Bioinformatics is an interdisciplinary research field that combines biology, computer science, mathematics and statistics into a broad-based field that will have profound impacts on all fields of biology. The emphasis of IJBRA is on basic bioinformatics research methods, tool development, performance evaluation and their applications in biology. IJBRA addresses the most innovative developments, research issues and solutions in bioinformatics and computational biology and their applications.

    BioMed Central


    BioMed Central is an online STM publisher of more than 270 peer-reviewed open access journals. The portfolio of journals spans all areas of biology, biomedicine and medicine, with many journals publishing content related to pulmonary medicine and allergy research. Examples of such journals include: COPD Research and Practice, Multidisciplinary Respiratory Medicine, Respiratory Research, and Allergy, Asthma & Clinical Immunology. All original research articles published by BioMed Central are made freely accessible online immediately upon publication. Authors publishing with BioMed Central retain copyright of their work, licensing it under the Creative Commons Attribution License which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited. BioMed Central is owned by Springer Science+Business Media, and also hosts the SpringerOpen platform.

    Swiss Biotech Association


    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.



    Biotechgate is a global, comprehensive, life science database covering the Biotech, Pharma and Medtech industries. There are currently over 38,000 company profiles on the Biotechgate database. Biotechgate is commonly used to find product pipelines, collaboration partners, in/out-licensing opportunities and information about technology platforms, management details, new business leads and financing rounds. In addition, our licensing deals database supports companies in negotiating their licensing agreements.

    Pharmaceutical Technology


    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.

    Int. J. of Immunological Studies


    IJIS publishes a broad range of papers on all aspects of immunology from scientists in academic and non-academic organisations as well as business and government worldwide. IJIS is the flagship journal of the Frontiers in Immunology Research Network.

    Lab Bulletin


    Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here

    Technology Networks


    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com

    Drug Target Review


    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.

    International Clinical Trials


    International Clinical Trials (ICT) aims to give its pharmaceutical, biotech and CRO readership the latest analysis on the trends affecting the community today. Topics covered in the magazine include the importance of emerging markets in a globalised economy, and the innovations being driven by large CROs and small speciality companies alike, giving voice to the opinions of both the trial investigator and the patient. Published quarterly, the magazine takes an operational view of the clinical research process, identifying ways to optimise the design, management and delivery of trials.

    Renaissance Woodbridge Hotel

    515 US Highway 1 South
    Iselin 08830

    Renaissance Woodbridge Hotel

    Your simple delights will become memorable moments at Renaissance Woodbridge Hotel. This distinctive hotel in Edison, New Jersey, features 269 modern guest rooms, including 42 suites, and more than 25,000 square feet of flexible meeting space. Our hotel's location is centrally located amidst corporate offices and tourist attraction. Our accommodations stand out from other hotels in Edison, NJ, and provide a sophisticated retreat for families and business travelers alike. Marriott's Plug-in panels and 37-inch LCD HD TVs allow guests simultaneous connectivity to laptops, iPods and DVD players. We are one of the most conveniently situated hotels at the crossroads of U.S. Routes 1 and 9. We are also just five minutes from Woodbridge Center Mall, 15 minutes south of Newark Liberty International Airport (EWR) and less than one mile from the Metropark train station. With our premier location and amenities, our Edison accommodations provide an advantageous travel destination.



    speaker image






    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title


    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event


    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71

    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out